DILIGENT PHARMA Trademark

Trademark Overview

On Friday, March 8, 2024, a trademark application was filed for DILIGENT PHARMA with the United States Patent and Trademark Office. The USPTO has given the DILIGENT PHARMA trademark a serial number of 98440018. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Thursday, November 21, 2024. This trademark is owned by Diligent Pharma, Inc.. The DILIGENT PHARMA trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:

Technical consulting the field of assisting with the selection of technical service providers for clinical trials; Technical consulting in the field of clinical trial vendor selection

Technical consulting in the field of pharmaceutical studies; Technical consulting in the field of conducting clinical trials, namely, assisting with the selection and management of technical service provider vendors for clinical trials; Technical consulting in the field of conducting clinical trials, namely, clinical trial third party vendor selection and management; Providing online non-downloadable software for assisting third parties in selecting technical service providers to manage clinical trials for the testing of drugs, biologics, and medical devices; Providing online non-downloadable software for clinical trial vendor selection and management
diligent pharma

General Information

Serial Number98440018
Word MarkDILIGENT PHARMA
Filing DateFriday, March 8, 2024
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateThursday, November 21, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesTechnical consulting the field of assisting with the selection of technical service providers for clinical trials; Technical consulting in the field of clinical trial vendor selection
NOT AVAILABLEPHARMA
Goods and ServicesTechnical consulting in the field of pharmaceutical studies; Technical consulting in the field of conducting clinical trials, namely, assisting with the selection and management of technical service provider vendors for clinical trials; Technical consulting in the field of conducting clinical trials, namely, clinical trial third party vendor selection and management; Providing online non-downloadable software for assisting third parties in selecting technical service providers to manage clinical trials for the testing of drugs, biologics, and medical devices; Providing online non-downloadable software for clinical trial vendor selection and management

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, November 21, 2024
Primary Code035
First Use Anywhere DateSunday, December 31, 2023
First Use In Commerce DateSunday, December 31, 2023
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, March 8, 2024
Primary Code042
First Use Anywhere DateSunday, December 31, 2023
First Use In Commerce DateSunday, December 31, 2023

Trademark Owner History

Party NameDiligent Pharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08542

Trademark Events

Event DateEvent Description
Friday, March 8, 2024NEW APPLICATION ENTERED
Monday, March 11, 2024TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, July 22, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 20, 2024ASSIGNED TO EXAMINER
Thursday, October 24, 2024NON-FINAL ACTION WRITTEN
Thursday, October 24, 2024NON-FINAL ACTION E-MAILED
Thursday, October 24, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 21, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 21, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 21, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED

Related Keywords

pharma diligent clinical technical consulting field selection trials trial vendor management assisting